Purinergic Signaling, Dyslipidemia and Inflammatory Disease
Authors:
- Daniel L. SparksDSDaniel L. Sparks
- Cynthia ChatterjeeCCCynthia Chatterjee
- 1 January 2012
- journal article
- review article
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 30 (6) , 1333-1339
Abstract
Metabolic syndrome is a compound obesity disorder, wherein the abnormal metabolism of glucose and lipid is associated with the development of chronic inflammatory diseases. The prevalence of this disease is increasing in the developed world, but the causative linkage between these metabolic disorders has remained obscure. Metabolic disease may be associated with chronic nucleotide secretion, purinergic signaling and activation of inflammatory pathways. Purinergic signaling has been implicated in impaired glucose metabolism and inflammatory disease and may contribute to dyslipidemia. Our research shows that purinergic signaling disrupts hepatic lipoprotein metabolism by blocking insulin receptor signaling and by activating cellular autophagic pathways. Chronic stimulation of purinergic signaling may therefore be causative to glucose and lipid metabolic disorders and associated with the development of cardiovascular disease.Keywords
This publication has 59 references indexed in Scilit:
- Mechanisms of ATP release and signalling in the blood vessel wallCardiovascular Research, 2012
- P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammationFrontiers in Bioscience-Scholar, 2011
- Extracellular nucleotides as negative modulators of immunityCurrent Opinion in Pharmacology, 2009
- Extracellular ATP in the Immune System: More Than Just a “Danger Signal”Science Signaling, 2009
- P2 receptors in cardiovascular regulation and diseasePurinergic Signalling, 2007
- CD39 and control of cellular immune responsesPurinergic Signalling, 2007
- Inhibition of Nitrobenzylthioinosine-Sensitive Adenosine Transport by Elevated d -Glucose Involves Activation of P 2Y2 Purinoceptors in Human Umbilical Vein Endothelial CellsCirculation Research, 2002
- P2 receptors: new potential players in atherosclerosisBritish Journal of Pharmacology, 2002
- Extracellular ATP and ADP Activate Transcription Factor NF-κB and Induce Endothelial Cell ApoptosisBiochemical and Biophysical Research Communications, 1998
- ATP, ADP and AMP in plasma from peripheral venous bloodClinica Chimica Acta, 1984